For HIV-1. See Full Indication.

CLINICAL TRIALS INVOLVING TIVICAY

TREATMENT-NAÏVE STUDIES

Dolutegravir-based regimens have been evaluated in the below four Phase 3, active-control, noninferiority, treatment-naïve trials

ViiV-Sponsored

SINGLE

vs EFAVIRENZ-based regimen

VIEW STUDY

ViiV-Sponsored

SPRING-2

vs RALTEGRAVIR-based regimen

VIEW STUDY

ViiV-Sponsored

FLAMINGO

vs DARUNAVIR-based regimen

VIEW STUDY

Gilead-Sponsored

STUDY 1490

vs BICTEGRAVIR-based regimen

VIEW STUDY

TREATMENT-EXPERIENCED STUDY

Dolutegravir-based regimens have been evaluated in the below Phase 3, treatment-experienced, INSTI-naïve trial

ViiV-Sponsored

SAILING

vs RALTEGRAVIR-based regimen

VIEW STUDY

DLTWCNT190003


INSTI=integrase strand transfer inhibitor.